All Insights

Energy and Energy Transition

Energy and Utilities Update | 21 August 2020

Welcome to our latest update on regulatory and market developments in the energy and utilities sector. In this week's edition

Employment and pensions

Singapore takes further measures to support employees

Initiatives and tiered approach demonstrate the Singapore government's recognition that continued financial support will be necessary to alleviate the hardship

The New Deal for Consumers

OC Consumer Briefing on search result transparency: What do businesses need to do to come out on top?

The New Deal for Consumer introduces new transparency obligations for businesses, including a requirement to disclose their search ranking criteria

Dispute resolution

Think your contract is clear, think again

With courts being increasingly willing to apply business common sense in favour of a strict, literal interpretation of contractual wording

Dispute resolution

Get ready for the new Dutch Franchise Act

On 15 July 2020 the introduction of the new Wet Franchise ("Franchise Act") was officially announced. The Franchise Act introduces

Energy and Energy Transition

Energy and Utilities Update | 14 August 2020

Welcome to our latest update on regulatory and market developments in the energy and utilities sector. In this week's edition

Tech, Media and Comms

Covid-19 and Brexit force DCMS to deprioritise rule changes in push to deliver telecoms directive

UK digital ministry postpones implementation of telecoms obligations on 'over the top' services but confirms they will be subject to

Tech, Media and Comms

Ofcom shifts on definitions in implementing the European Electronic Communications Code

Telecoms industry feedback prompts regulator to significantly change proposals for defining categories of business and for the scope of annual

Life Sciences and Healthcare

A shot in the arm for generics as UK courts refuse injunction to prevent potential patent infringement

In an unusual decision for life sciences patent disputes, the UK courts refused to restrain a generic drug manufacturer from